MARETTI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.697
AS - Asia 4.741
EU - Europa 4.172
SA - Sud America 709
AF - Africa 100
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.511
SG - Singapore 1.425
CN - Cina 1.140
GB - Regno Unito 1.138
IT - Italia 1.124
VN - Vietnam 620
BR - Brasile 552
HK - Hong Kong 535
SE - Svezia 495
DE - Germania 311
BD - Bangladesh 228
FR - Francia 210
RU - Federazione Russa 196
FI - Finlandia 173
IN - India 164
KR - Corea 137
UA - Ucraina 123
CA - Canada 96
TR - Turchia 95
ID - Indonesia 66
NL - Olanda 66
BG - Bulgaria 65
BE - Belgio 63
AR - Argentina 62
JP - Giappone 62
MX - Messico 51
PL - Polonia 42
AU - Australia 38
IQ - Iraq 37
PK - Pakistan 31
IR - Iran 27
EC - Ecuador 24
ES - Italia 23
LT - Lituania 23
ZA - Sudafrica 23
AE - Emirati Arabi Uniti 20
PH - Filippine 20
CL - Cile 19
IE - Irlanda 19
CO - Colombia 18
KE - Kenya 16
MY - Malesia 16
MA - Marocco 14
VE - Venezuela 13
AZ - Azerbaigian 12
TW - Taiwan 12
UZ - Uzbekistan 12
AT - Austria 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
EG - Egitto 9
IL - Israele 9
JM - Giamaica 9
JO - Giordania 9
NP - Nepal 9
RS - Serbia 9
TH - Thailandia 9
CH - Svizzera 8
PE - Perù 8
RO - Romania 8
HU - Ungheria 7
PT - Portogallo 7
PY - Paraguay 7
GR - Grecia 6
KZ - Kazakistan 6
MD - Moldavia 6
SA - Arabia Saudita 6
BY - Bielorussia 5
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
GE - Georgia 5
EE - Estonia 4
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
AL - Albania 3
BB - Barbados 3
BO - Bolivia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
ML - Mali 3
MN - Mongolia 3
PA - Panama 3
SV - El Salvador 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
Totale 17.444
Salva come PNG Salva come JPEG
Città #
Singapore 914
Santa Clara 828
Ashburn 778
Southend 721
Fairfield 571
Chandler 541
Hong Kong 517
San Jose 383
Woodbridge 356
Nyköping 257
Hefei 249
Dearborn 240
Beijing 233
Houston 233
Ann Arbor 225
Wilmington 217
Modena 209
Jacksonville 208
Ho Chi Minh City 196
Seattle 191
London 179
Cambridge 175
Hanoi 153
Council Bluffs 144
Los Angeles 138
The Dalles 127
Helsinki 126
New York 120
Seoul 120
Milan 84
Princeton 62
Moscow 60
Lauterbourg 58
Sofia 58
San Diego 54
Bremen 53
Redwood City 51
Frankfurt am Main 50
Eugene 48
Buffalo 46
Shanghai 44
Fremont 43
São Paulo 42
Izmir 40
Rome 39
Tokyo 39
Da Nang 38
Chicago 37
Dallas 37
Brussels 36
Jakarta 36
Columbus 35
Bologna 33
Ottawa 33
Warsaw 33
Munich 30
Orem 29
Chennai 24
Haiphong 23
Mumbai 23
Formigine 22
Mexico City 22
Parma 22
Porto Alegre 22
Rio de Janeiro 22
Basingstoke 20
Montreal 20
Amsterdam 19
Denver 19
Sydney 19
Falls Church 18
Guangzhou 18
San Francisco 17
Boardman 16
Atlanta 15
Hangzhou 15
Naples 15
New Delhi 15
Charlotte 13
Dublin 13
Johannesburg 13
Nanjing 13
Napoli 13
Quito 13
Reggio Nell'emilia 13
Belo Horizonte 12
Kunming 12
La Puente 12
Lappeenranta 12
Nairobi 12
Nuremberg 12
Phoenix 12
Baghdad 11
Brooklyn 11
Dhaka 11
Gurgaon 11
Hyderabad 11
Kent 11
Belfast 10
Biên Hòa 10
Totale 11.264
Salva come PNG Salva come JPEG
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 413
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 400
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 398
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 381
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 379
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 375
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 375
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 354
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 352
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 351
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 340
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 337
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 334
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 329
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 320
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 314
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 309
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 301
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 300
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 292
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 288
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 284
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 280
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 271
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 271
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 266
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 265
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 259
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 257
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 253
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 251
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 250
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 249
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 243
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 240
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 236
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 235
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 231
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 227
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 226
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 223
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 218
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 217
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 212
Formulazione per veicolare principi attivi lipofili 210
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 196
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 189
Medicinal Chemistry drives drug targeted delivery: a successful interplay 185
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 182
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 179
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 177
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 177
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 167
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 166
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 166
Formulazione per veicolare principi attivi lipofili 162
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 161
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 160
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 160
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 158
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 148
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 145
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 137
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability 136
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 123
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 119
Inhaled lipid nanoparticles: a feasible tool for a challenging route 116
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 102
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 100
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 95
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 94
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 90
Dispositivo per la somministrazione intravaginale di batteri e loro metaboliti 87
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 87
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 85
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 78
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 76
Development of a Heparin-Loaded Polyelectrolyte Complex for pH-Responsive Wound Healing Applications 68
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 68
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 52
Totale 17.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.308 33 77 119 59 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20253.311 78 30 118 227 601 429 311 249 359 156 342 411
2025/20266.021 389 199 432 559 785 388 914 388 671 644 374 278
2026/2027156 156 0 0 0 0 0 0 0 0 0 0 0
Totale 17.707